For decades, nicotine regulation has been built upon laboratory science, toxicological assessments, and clinical research. These forms of evidence remain indispensable for understanding product chemistry, biological mechanisms, and potential health
Why Evidence Matters in Public Health Communication A recent article published by Stanford Medicine, “Nicotine Pouches: The Tobacco Industry’s Latest Ploy?”, raises legitimate concerns about nicotine addiction and youth uptake.
From 1 August 2026, Finland will complete one of Europe’s most comprehensive regulatory frameworks for nicotine pouches as standardized plain packaging requirements become fully mandatory. The measures represent the final
As nicotine pouches continue to emerge within tobacco harm reduction discussions, policymakers are increasingly faced with a fundamental question: how should the health risks of these products be assessed? Public
Public health policy depends on informed decision-making. Whether developing regulation, advising patients, or supporting smoking cessation, decisions are only as effective as the information on which they are based. When
Smoking during pregnancy remains one of the most significant preventable causes of adverse maternal and infant health outcomes worldwide. It increases the risk of miscarriage, placental complications, preterm birth, low
The rapid emergence of oral nicotine pouches has presented policymakers with a familiar challenge. Innovation is moving faster than legislation, forcing regulators to determine how new products fit within legal
Every year, the United States Food and Drug Administration’s National Youth Tobacco Survey (NYTS) provides one of the most closely watched snapshots of tobacco and nicotine use among young people.
As tobacco-free nicotine pouches become more widely available, understanding their effects on oral health has become an important area of scientific research. Every new study contributes to a growing evidence
Recent commentary from researchers at Stanford University has reignited debate over nicotine pouches, describing them as the latest strategy by the tobacco industry to sustain nicotine addiction while raising concerns
As governments around the world grapple with the rapid emergence of modern nicotine products, a common regulatory challenge is becoming increasingly apparent. How can policymakers protect public health while ensuring
Public health discussions surrounding problematic drug use often focus on overdose prevention, infectious diseases, mental health, and access to treatment services. Yet one of the most significant contributors to illness